Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2616)
All Articles published online
|
Apr 7, 2009 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tan T, Lawrance IC. Use of mycophenolate mofetil in inflammatory bowel disease. World J Gastroenterol 2009; 15(13): 1594-1599 [PMID: 19340901 DOI: 10.3748/wjg.15.1594] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i13/1594.htm |
| Number | Citing Articles |
| 1 |
Yezaz A Ghouri, Veysel Tahan, Bo Shen. Secondary causes of inflammatory bowel diseases. World Journal of Gastroenterology 2020; 26(28): 3998-4017 doi: 10.3748/wjg.v26.i28.3998
|
| 2 |
Antony Pan, Martin Schlup, Ralf Lubcke, Michael Schultz. Fulminant ulcerative colitis despite maximal immunosuppression following liver transplantation: A case report and literature review. Journal of Crohn's and Colitis 2011; 5(5): 465 doi: 10.1016/j.crohns.2011.04.011
|
| 3 |
Brendan G. Dwyer, Chao Wang, Daniel Abegg, Brittney Racioppo, Nan Qiu, Zhensheng Zhao, Dany Pechalrieu, Anton Shuster, Dominic G. Hoch, Alexander Adibekian. Chemoproteomics‐Enabled De Novo Discovery of Photoswitchable Carboxylesterase Inhibitors for Optically Controlled Drug Metabolism. Angewandte Chemie International Edition 2021; 60(6): 3071 doi: 10.1002/anie.202011163
|
| 4 |
Rossella Gioco, Daniela Corona, Burcin Ekser, Lidia Puzzo, Gaetano Inserra, Flavia Pinto, Chiara Schipa, Francesca Privitera, Pierfrancesco Veroux, Massimiliano Veroux. Gastrointestinal complications after kidney transplantation. World Journal of Gastroenterology 2020; 26(38): 5797-5811 doi: 10.3748/wjg.v26.i38.5797
|
| 5 |
Matthew R. Smith, Sheldon C. Cooper. Mycophenolate mofetil therapy in the management of inflammatory bowel disease — A retrospective case series and review. Journal of Crohn's and Colitis 2014; 8(8): 890 doi: 10.1016/j.crohns.2014.01.014
|
| 6 |
Morris Gordon, Adrian G Thomas, Anthony K Akobeng. Mycophenolate mofetil for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2011; doi: 10.1002/14651858.CD009123
|
| 7 |
Hamidreza Sohbati, Mohsen Amini, Saeed Balalaie. Synthesis and Biological Evaluation of Novel Anti-leukemia Proteolysis-Targeting Chimeras in Degradating Inosine Monophosphate Dehydrogenase. Iranian Journal of Pharmaceutical Research 2022; 21(1) doi: 10.5812/ijpr-129251
|
| 8 |
Fabio Salvatore Macaluso, Marcello Maida, Sara Renna, Emanuele Orlando, Marco Affronti, Chiara Sapienza, Mariangela Dimarco, Rosalba Orlando, Giulia Rizzuto, Mario Cottone, Ambrogio Orlando. Mycophenolate mofetil is a valid option in patients with inflammatory bowel disease resistant to TNF-α inhibitors and conventional immunosuppressants. Digestive and Liver Disease 2017; 49(2): 157 doi: 10.1016/j.dld.2016.10.001
|
| 9 |
|
| 10 |
Jeffrey Jacobs, Kindra Clark-Snustad, Scott Lee. Deep Remission in Severe Refractory Crohn’s Disease With Mycophenolate Mofetil. Inflammatory Bowel Diseases 2023; 29(2): 332 doi: 10.1093/ibd/izac213
|
| 11 |
Sara Renna, Mario Cottone, Ambrogio Orlando. Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease. World Journal of Gastroenterology 2014; 20(29): 9675-9690 doi: 10.3748/wjg.v20.i29.9675
|
| 12 |
Syed A. Rizvi. Clinical Neuroimmunology. Current Clinical Neurology 2020; : 137 doi: 10.1007/978-3-030-24436-1_7
|
| 13 |
Johannes Söllner, Paul Mayer, Andreas Heinzel, Raul Fechete, Christian Siehs, Rainer Oberbauer, Bernd Mayer. Synthetic lethality for linking the mycophenolate mofetil mode of action with molecular disease and drug profiles. Molecular BioSystems 2012; 8(12): 3197 doi: 10.1039/c2mb25256b
|
| 14 |
Jeffery M Venner, Charles N Bernstein. Immunomodulators: still having a role?. Gastroenterology Report 2022; 10 doi: 10.1093/gastro/goac061
|
| 15 |
Scott M. Whitlock, Clinton W. Enos, April W. Armstrong, Alice Gottlieb, Richard G. Langley, Mark Lebwohl, Joseph F. Merola, Caitriona Ryan, Michael P. Siegel, Jeffrey M. Weinberg, Jashin J. Wu, Abby S. Van Voorhees. Management of psoriasis in patients with inflammatory bowel disease: From the Medical Board of the National Psoriasis Foundation. Journal of the American Academy of Dermatology 2018; 78(2): 383 doi: 10.1016/j.jaad.2017.06.043
|
| 16 |
Kalle Landerholm, Disa Kalman, Conny Wallon, Pär Myrelid. Immunomodulators: Friends or Enemies in Surgery for Crohn’s Disease?. Current Drug Targets 2019; 20(13): 1384 doi: 10.2174/1389450120666190617163919
|
| 17 |
Brendan G. Dwyer, Chao Wang, Daniel Abegg, Brittney Racioppo, Nan Qiu, Zhensheng Zhao, Dany Pechalrieu, Anton Shuster, Dominic G. Hoch, Alexander Adibekian. Chemoproteomics‐Enabled De Novo Discovery of Photoswitchable Carboxylesterase Inhibitors for Optically Controlled Drug Metabolism. Angewandte Chemie 2021; 133(6): 3108 doi: 10.1002/ange.202011163
|
| 18 |
Ian C Lawrance. Early investigational TNF receptor antagonists for the treatment of ulcerative colitis. Expert Opinion on Investigational Drugs 2015; 24(6): 761 doi: 10.1517/13543784.2015.1020371
|
| 19 |
|
| 20 |
Ning Zhou, Wei-xing Chen, Shao-hua Chen, Cheng-fu Xu, You-ming Li. Inflammatory bowel disease unclassified. Journal of Zhejiang University SCIENCE B 2011; 12(4): 280 doi: 10.1631/jzus.B1000172
|
| 21 |
P. Azevedo, C. Freitas, P. Aguiar, H. Silva, T. Santos, P. Farrajota, M. Almeida, S. Pedroso, L.S. Martins, L. Dias, R. Vizcaíno, A. Castro Henriques, A. Cabrita. A Case Series of De Novo Inflammatory Bowel Disease After Kidney Transplantation. Transplantation Proceedings 2013; 45(3): 1084 doi: 10.1016/j.transproceed.2013.03.008
|
| 22 |
Jiayun M Fang, Laura Lamps, Amoah Yeboah-Korang, Jerome Cheng, Maria Westerhoff. De Novo Inflammatory Bowel Disease Rarely Occurs During Posttransplant Immunosuppression. American Journal of Clinical Pathology 2021; 156(6): 1113 doi: 10.1093/ajcp/aqab084
|
| 23 |
Michael Friedt, Christian P. Braegger. Pädiatrische Gastroenterologie, Hepatologie und Ernährung. 2013; : 333 doi: 10.1007/978-3-642-24710-1_11
|
| 24 |
A. Hernández-Camba, L. Arranz, I. Vera, D. Carpio, M. Calafat, A.J. Lucendo, C. Taxonera, S. Marín, M.J. Garcia, G. Suris Marín, E. Sánchez Rodríguez, A.Y. Carbajo, M.L. De Castro, M. Iborra, A. Martin-Cardona, I. Rodríguez-Lago, D. Busquets, F. Bertoletti, M. Sierra Ausín, C. Tardillo, J. Huguet Malaves, L. Bujanda, A. Castaño, E. Domènech, L. Ramos, O. Merino. Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry. Digestive and Liver Disease 2022; 54(5): 635 doi: 10.1016/j.dld.2021.10.002
|
| 25 |
Marie-France Dubeau, Marietta Iacucci, Paul L. Beck, Gordon W. Moran, Gilaad G. Kaplan, Subrata Ghosh, Remo Panaccione. Drug-Induced Inflammatory Bowel Disease and IBD-Like Conditions. Inflammatory Bowel Diseases 2013; 19(2): 445 doi: 10.1002/ibd.22990
|
| 26 |
KaranRajgopal Kalani, AnujAchyut Ban, Sumeet Singla. Co-existing ulcerative colitis and takayasu arteritis: A case-based review. Indian Journal of Rheumatology 2022; 17(4): 416 doi: 10.4103/injr.injr_290_21
|